ZEPTOROZ Trademark

Trademark Overview


On Tuesday, May 16, 2017, a trademark application was filed for ZEPTOROZ with the United States Patent and Trademark Office. The USPTO has given the ZEPTOROZ trademark a serial number of 87451237. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, September 9, 2024. This trademark is owned by Celgene Corporation. The ZEPTOROZ trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in the treatment of multiple sclerosis, leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
zeptoroz

General Information


Serial Number87451237
Word MarkZEPTOROZ
Filing DateTuesday, May 16, 2017
Status710 - CANCELLED - SECTION 8
Status DateMonday, September 9, 2024
Registration Number5411010
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements


Goods and Servicespharmaceutical preparations for use in the treatment of multiple sclerosis, leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Translation of Words in MarkThe wording "ZEPTOROZ" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, September 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Monday, May 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 25, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 19, 2017NEW APPLICATION ENTERED
Sunday, July 16, 2017ASSIGNED TO EXAMINER
Sunday, July 16, 2017NON-FINAL ACTION WRITTEN
Sunday, July 16, 2017NON-FINAL ACTION E-MAILED
Sunday, July 16, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 6, 2017ASSIGNED TO LIE
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 9, 2024CANCELLED SEC. 8 (6-YR)